ACTU
Price
$1.50
Change
+$0.29 (+23.97%)
Updated
Jul 13 closing price
Capitalization
35.89M
50 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$16.90
Change
-$0.03 (-0.18%)
Updated
Jul 13 closing price
Capitalization
875.9M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACTU vs TBPH

ACTU vs TBPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACTU vs. TBPH commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACTU is a Hold and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ACTU: $1.50 vs. TBPH: $16.90)
Brand notoriety: ACTU and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACTU: 832% vs. TBPH: 73%
Market capitalization -- ACTU: $35.89M vs. TBPH: $875.9M
ACTU [@Biotechnology] is valued at $35.89M. TBPH’s [@Biotechnology] market capitalization is $875.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACTU’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 1 green FA rating(s).

  • ACTU’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 1 green, 4 red.
According to our system of comparison, TBPH is a better buy in the long-term than ACTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACTU’s TA Score shows that 4 TA indicator(s) are bullish while TBPH’s TA Score has 5 bullish TA indicator(s).

  • ACTU’s TA Score: 4 bullish, 4 bearish.
  • TBPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ACTU and TBPH are a good buy in the short-term.

Price Growth

ACTU (@Biotechnology) experienced а +7.14% price change this week, while TBPH (@Biotechnology) price change was -0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ACTU is expected to report earnings on Sep 02, 2026.

TBPH is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($876M) has a higher market cap than ACTU($35.9M). TBPH has higher P/E ratio than ACTU: TBPH (7.58) vs ACTU (6.50). TBPH YTD gains are higher at: -9.674 vs. ACTU (-75.490). TBPH has higher annual earnings (EBITDA): 141M vs. ACTU (-21.52M). TBPH has more cash in the bank: 395M vs. ACTU (8.13M). TBPH has higher revenues than ACTU: TBPH (110M) vs ACTU (0).
ACTUTBPHACTU / TBPH
Capitalization35.9M876M4%
EBITDA-21.52M141M-15%
Gain YTD-75.490-9.674780%
P/E Ratio6.507.5886%
Revenue0110M-
Total Cash8.13M395M2%
Total DebtN/A40.5M-
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
20
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACTUTBPH
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
58%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
90%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
62%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
58%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ACTU
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAECX21.31N/A
N/A
Putnam Dynamic Asset Allocation Gr C
JSVPX30.47N/A
N/A
JPMorgan Small Cap Value R3
MAGKX17.84N/A
N/A
MoA Small Cap Growth Fund
GGINX14.20N/A
N/A
Goldman Sachs Global Infras Inv
RAFFX46.71-0.54
-1.14%
American Funds AMCAP R-5

ACTU and

Correlation & Price change

A.I.dvisor tells us that ACTU and TBPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTU and TBPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACTU
1D Price
Change %
ACTU100%
+23.97%
TBPH - ACTU
31%
Poorly correlated
-0.18%
LCTX - ACTU
29%
Poorly correlated
-5.47%
CADL - ACTU
28%
Poorly correlated
+1.58%
SYRE - ACTU
28%
Poorly correlated
-4.10%
PDSB - ACTU
27%
Poorly correlated
-3.71%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with SPRC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-0.18%
SPRC - TBPH
36%
Loosely correlated
-4.89%
KYMR - TBPH
35%
Loosely correlated
-7.50%
AXON - TBPH
34%
Loosely correlated
-3.32%
ARRY - TBPH
34%
Loosely correlated
-3.92%
DNLI - TBPH
33%
Loosely correlated
+3.12%
More